Gatifloxacin Ophthalmic

283 interactions 389 cited references
Also sold as: Zymar® Zymaxid Zymaxid®
About Gatifloxacin Ophthalmic

Gatifloxacin ophthalmic solution is used to treat bacterial conjunctivitis (pinkeye; infection of the membrane that covers the outside of the eyeballs and the inside of the eyelids) in adults and children 1 year of age and older. Gatifloxacin is in a class of antibiotics called fluoroquinolones. It works by killing the… Read the full Gatifloxacin Ophthalmic drug information page →

Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Aug 9, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Dronedarone Levoketoconazole Mesoridazine Pimozide Piperaquine Saquinavir
12 Contraindicated 254 Major 17 Moderate
All (283) Contraindicated (12) Major (254) Moderate (17)

Major

Gatifloxacin Ophthalmic Milsaperidone An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Mirtazapine Mirataz Increased risk of QT interval prolongation and torsades de pointes Details Gatifloxacin Ophthalmic Mobocertinib Exkivity An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Moricizine An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Moxifloxacin Avelox Increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Nateglinide Starlix® Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Gatifloxacin Ophthalmic Nelfinavir Viracept Increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Nilotinib An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Norfloxacin An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Nortriptyline An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Gatifloxacin Ophthalmic Octreotide Bynfezia An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Ofloxacin Floxin® An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Olanzapine An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Olodaterol Striverdi An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Gatifloxacin Ophthalmic Ondansetron An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Opipramol An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Gatifloxacin Ophthalmic Osilodrostat Isturisa Increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Osimertinib Tagrisso Increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Oxaliplatin Increased risk of QT-interval prolongation Details Gatifloxacin Ophthalmic Ozanimod Additive effects on heart rate Details Gatifloxacin Ophthalmic Pacritinib Vonjo® An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Paliperidone Erzofri An increased risk of QT interval prolongation and torsade de pointes Details Gatifloxacin Ophthalmic Panobinostat Farydak Increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Paroxetine Paxil An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Pasireotide Signifor Increased risk of QT prolongation Details Gatifloxacin Ophthalmic Pazopanib Votrient Increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Perphenazine An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Gatifloxacin Ophthalmic Phenobarbital Fidoquel An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Pimavanserin Nuplazid An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Pioglitazone Actos Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Gatifloxacin Ophthalmic Pipotiazine An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Gatifloxacin Ophthalmic Pitolisant Wakix Increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Ponesimod Ponvory An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Porfimer Excessive intracellular damage in photosensitized tissues Details Gatifloxacin Ophthalmic Posaconazole Noxafil An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Pramlintide Symlin Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Gatifloxacin Ophthalmic Prednisolone Flo-Pred® An increased risk of tendon rupture Details Gatifloxacin Ophthalmic Prednisone Deltasone An increased risk of tendon rupture Details Gatifloxacin Ophthalmic Primidone Mysoline An increased risk of QT interval prolongation Details Gatifloxacin Ophthalmic Procainamide Procan® An increased risk of QT interval prolongation Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.